Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 25;13(4):443. doi: 10.3390/pharmaceutics13040443

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Effects of compounds 1–15 and N^G-monomethyl-L-arginine mono-acetate salt (L-NMMA) in RAW 264.7 mouse macrophages treated with lipopolysaccharide (LPS). (A–P) The effects of compounds 1–15 and L-NMMA in RAW 264.7 mouse macrophages treated with LPS were investigated (mean ± SD, *p < 0.05 compared to group treated with 1 μg/mL LPS alone). 5α-Stigmast-3,6-dione (1), 3β-sitostanol (2), 6α-hydroxy-β-sitostenone (3), 6β-hydroxysitostenone (4), norphytan (5), phytone (6), methyl 3-O-acetylbetulinate (7), 3-O-acetylbetulin (8), sitostenone (9), leucophyllone (10), lupeol (11), lupenone (12), betulinic acid (13), betulinic acid methyl ester (14), and benzyl salicylate (15).